Local Antibiotic Delivery for Community Acquired Pneumonia

Summary

A randomized, double-blinded clinical pilot study to assess whether addition of inhaled levofloxacin 240 mg twice daily for three days leads to improved or worsened physiological status in CAP patients with and without pre-existing lung disease.

Timeline

Start

2025-03-04

Primary completion

2025-09-01

Completion

2028-09-01

Drugs

Indications